Clinical Trials Directory

Trials / Completed

CompletedNCT00692887

Correlation Between Visual Field Defects on Foresee Preferential Hyperacuity Perimeter(PHP) and on Optical Coherence Tomography (OCT) in Patients With Choroidal Neovascularization (CNV)

Correlation Between Visual Field Defects on Foresee PHP and OCT in Patients With CNV Before and After Treatment

Status
Completed
Phase
Study type
Observational
Enrollment
15 (actual)
Sponsor
Notal Vision Ltd. · Industry
Sex
All
Age
50 Years
Healthy volunteers
Not accepted

Summary

Study come to investigate the correlation between visual fields (VF) defects map generated by preferential hyperacuity perimeter (PHP) and features of the choroidal neovascular lesions (CNV) demonstrated by Optical Coherence Tomography(OCT). To investigate the Foresee PHP ability to asses treatment progression post treatment.

Detailed description

The Foresee PHP is used in the recent years to detect Age-related Macular Degeneration (AMD) lesions. The device is capable of differentiation as to stages of AMD and early detection of changes including choroidal neovascularization (CNV) The Foresee PHP™ demonstrates a high level of sensitivity and specificity as to the different stages of AMD including newly diagnosed or early detection of CNV. The OCT May be use as well to identify choroidal neovascularization (CNV). Comparison between the two methods will allow better understanding of both devices. The Foresee PHP can use as an assessment tool for the progression and success of the treatment given to AMD lesions. Therefore, evaluation the size and the location of the treated lesions may serve as an additional tool.

Conditions

Interventions

TypeNameDescription
DEVICEPHP - Preferential Hyperacuity Perimeter (Foresee)computerized test

Timeline

Start date
2008-06-01
Primary completion
2008-12-01
Completion
2009-01-01
First posted
2008-06-06
Last updated
2009-01-28

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT00692887. Inclusion in this directory is not an endorsement.